Filing Details
- Accession Number:
- 0001654954-17-011655
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-14 16:13:56
- Reporting Period:
- 2017-12-12
- Accepted Time:
- 2017-12-14 16:13:56
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1410098 | Cormedix Inc. | CRMD | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1489798 | Janet Dillione | One Wayside Road Burlington MA 01803 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-12-12 | 52,083 | $0.48 | 92,052 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Phantom Stock | $0.00 | 15,625 | 15,625 | Direct | ||
Common Stock | Phantom Stock | $0.00 | 20,833 | 20,833 | Direct | ||
Common Stock | Stock Option (Right to Buy Common Stock) | $2.24 | 2027-02-21 | 40,000 | 40,000 | Direct | |
Common Stock | Restricted Stock Units | $0.00 | 15,357 | 15,357 | Direct | ||
Common Stock | Phantom Stock | $0.00 | 3,472 | 3,472 | Direct | ||
Common Stock | Phantom Stock | $0.00 | 4,143 | 4,143 | Direct | ||
Common Stock | Stock Option (Right to Buy Common Stock) | $3.03 | 2025-08-11 | 50,000 | 50,000 | Direct | |
Common Stock | Phantom Stock | $0.00 | 1,415 | 1,415 | Direct | ||
Common Stock | Stock Option (Right to Buy Common Stock) | $1.91 | 2026-02-21 | 95,000 | 95,000 | Direct | |
Common Stock | Phantom Stock | $0.00 | 3,831 | 3,831 | Direct | ||
Common Stock | Phantom Stock | $0.00 | 2,767 | 2,767 | Direct | ||
Common Stock | Phantom Stock | $0.00 | 4,335 | 4,335 | Direct | ||
Common Stock | Phantom Stock | $0.00 | 15,306 | 15,306 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
15,625 | 15,625 | Direct | |
20,833 | 20,833 | Direct | |
2027-02-21 | 40,000 | 40,000 | Direct |
15,357 | 15,357 | Direct | |
3,472 | 3,472 | Direct | |
4,143 | 4,143 | Direct | |
2025-08-11 | 50,000 | 50,000 | Direct |
1,415 | 1,415 | Direct | |
2026-02-21 | 95,000 | 95,000 | Direct |
3,831 | 3,831 | Direct | |
2,767 | 2,767 | Direct | |
4,335 | 4,335 | Direct | |
15,306 | 15,306 | Direct |
Footnotes
- Purchase was contracted on November 17, 2017, but not closed until December 12, 2017.
- Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.
- These options were granted on 2/21/2017. The options vest in full on the first anniversary of the date of grant, subject to continued service on the board.
- These Restricted Stock Units were granted on 2/21/2017. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board.
- These options were granted on 8/12/2015. The options vest as follows: 1/3 on 8/12/2015, 1/3 on 8/12/2016, and 1/3 on 8/12/2017.
- These options were granted on 2/21/2016. These options vest in full on the first anniversary of the date of grant, subject to continued service on the board.